Cancer is one of the leading causes of death worldwide, and while early detection plays a crucial role in improving survival rates, many patients still lack access to advanced cancer treatment in Malaysia. Stemcell First Group, a pioneering healthcare provider, is transforming the landscape of cancer care in the region with immunotherapy, gene therapy, and regenerative medicine.
Innovative And Personalised Cancer Treatment In Malaysia
Founded in 2016, Stemcell First Group specialises in immunotherapy, gene therapy, and regenerative medicine. Their therapies are produced in current Good Manufacturing Practice (cGMP) laboratories, ensuring the highest standards of safety and efficacy.
Guided by the belief that everyone deserves access to the latest, evidence-based cancer treatments, Stemcell First prioritises offering innovative solutions that are both accessible and affordable to patients in Malaysia and across Southeast Asia.
Early Detection For Better Cancer Outcomes
Stemcell First offers Multiple Cancer Early Detection (MCED) screenings, a game-changing tool in cancer prevention. The screenings can identify multiple types of cancer, including breast, lung, colorectal, pancreatic, prostate, stomach, esophageal, liver, and uterine cancers, even before symptoms appear. Through these screenings, detecting cancers as early as stage 0 empowers patients to take proactive steps to reduce treatment costs and improve survival rates. The Chief Operating Officer of Stemcell First Group, Allen Law emphasised:
It cannot be emphasised any clearer that early detection is the key to saving lives. Our MCED screening service ensures that patients have the chance to address cancer risks earlier before they become life-threatening and provide the applicable solution to mitigate the risk, aligning with our mission to bring advanced care closer to home.
Allen Law, Chief Operating Officer of Stemcell First Group
Innovative Cancer Therapies
The Vanfo Hino Ambulatory Care Centre (ACC) in Johor Bahru is at the forefront of Stemcell First’s cancer care efforts. This advanced facility specialises in both cell and gene therapies for cancer treatment, including CAR-T cell therapy. CAR-T cell therapy is used to target various cancers, such as leukaemia, lymphoma, myeloma, pancreatic cancer, ovarian cancer, colorectal cancer, melanoma, sarcoma, and bladder cancer. With these world-class treatments locally, Stemcell First makes advanced cancer treatment in Malaysia more accessible and affordable for patients.
A Future Of Hope And Healing
Stemcell First’s commitment extends beyond treatment to igniting hope and fostering healing in patients. As the group expands its reach across Southeast Asia, its goal is to make advanced cancer treatments accessible to even more patients, helping to bridge the healthcare gap in the region. The Advisor of Stemcell First, Richard Lim shared:
At Stemcell First, we are committed to the patient first before we embark on redefining healthcare. Our journey is just beginning, and we are excited to continue bringing hope, healing, and innovative medical solutions to the different communities we serve in the present and in the near future.
Richard Lim, Advisor of Stemcell First
For more information about Stemcell First, visit the website by clicking here.
